Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000950123-25-000372
Filing Date
2025-01-17
Accepted
2025-01-17 16:30:21
Documents
1
Effectiveness Date
2025-01-17
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11275
  Complete submission text file 0000950123-25-000372.txt   12606
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: D | Act: 33 | File No.: 021-535685 | Film No.: 25539083
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)